February 01, 2022
Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden
Media
February 01, 2022
Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration
January 31, 2022
Xeris Biopharma Announces Recorlev® (levoketoconazole) Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
January 24, 2022
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
January 21, 2022
Elsa Science appoints new Chairman of the Board, Niklas Eklund
January 21, 2022
Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US – no intent to market in the US at this time
January 19, 2022
Nordic Nanovector ASA – Private placement of new shares successfully placed
January 18, 2022
Xeris Biopharma Reaffirms 2021 Guidance and Provides Business Update
January 17, 2022
Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan
January 13, 2022
BONESUPPORT signs distribution agreement with OrthoPediatrics
